Read + Share
Amedeo Smart
Independent Medical Education
Park HY, Chae MK, Ko J, Kikkawa DO, et al. Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy. PLoS One 2022;17:e0279060.PMID: 36521376
Email
LinkedIn
Facebook
Twitter
Privacy Policy